Home-based Self-sampling for Cervical Cancer Prevention Education Intervention in Ghana
Launched by BAYLOR UNIVERSITY · Jan 28, 2025
Trial Information
Current as of June 27, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on improving cervical cancer prevention in Ghana by developing a program called the HOPE intervention. It aims to help healthcare providers learn how to better support women in getting screened for cervical cancer, especially those living with HIV. The goal is to make it easier for women to access screening services and to ensure that these services become a regular part of healthcare in their communities.
To participate in this trial, women must be between 25 and 65 years old, living with HIV, and have never had a cervical cancer screening before or not had one in the past five years. Women who are pregnant or have had a hysterectomy cannot participate. Participants can expect to be part of a program that includes training and support to help them understand the importance of cervical cancer screening. This trial is still in the planning stages and is not yet recruiting participants.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • General criteria
- • ability to give consent per Institutional Review Board stipulations
- • residing in the Central Region
- • having no medical characteristics that would interfere with the ability to participate fully
- • the willingness to participate in this study.
- • (a) Healthcare provider eligibility: Inclusion criteria include an individual (no gender restrictions) who
- • possesses healthcare qualifications (i.e., patient navigators, physicians, nurses, health facility management),
- • works at the HIV health facility at study sites,
- • is ≥18 years old. (b) Eligibility for women living with HIV (Patients)
- • identified female at birth) who
- • are living with HIV between 25 and 65 years old (age consistent with WHO CC screening guidelines)
- • have never had CC screening (Pap or HPV test),
- • have not had a screening for the past 5 years
- Exclusion Criteria:
- • Women will be excluded if they are pregnant or have had a hysterectomy.
- • WLWH who have a cervix are the main target population to develop the HOPE toolkit.
- • Women who are below 25 and those who are above 65 years will be excluded.
About Baylor University
Baylor University is a prestigious academic institution recognized for its commitment to advancing medical research and healthcare innovation. The university actively sponsors clinical trials aimed at improving patient outcomes and understanding various health conditions. Leveraging a multidisciplinary approach, Baylor University integrates expertise from its renowned faculty across diverse fields, including medicine, public health, and biomedical sciences. Through rigorous scientific inquiry and collaboration with healthcare professionals, Baylor University endeavors to translate research findings into practical applications that enhance clinical practice and patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Capte Coast, Central Region, Ghana
Patients applied
Trial Officials
Matthew Asare, PhD
Principal Investigator
Baylor University
Dorcas Obiri-Yeboah, PhD
Principal Investigator
University of Cape Coast
Nadia Sam-Agudu, MD
Principal Investigator
University of Minnesota
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported